FDA Approved: ZOLINZA — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved Zolinza (vorinostat) under original NDA for cutaneous T-cell lymphoma, marking the first approval of this histone deacetylase inhibitor for CTC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• Zolinza (vorinostat)

Snippet

ORIG AP for ZOLINZA (VORINOSTAT)